GN launches new technology platform to address the No.1 hearing aid challenge: hearing speech in noise
GN Hearing, the global leader in hearing aid innovation, today announces the launch of ReSound OMNIA – a new hearing aid platform that will set a new standard in hearing technology and improve how people interact with the world around them. ReSound OMNIA provides significantly better hearing in noisy environments than any previous ReSound hearing aid. Coupled with optimal comfort and seamless connection to devices, these advances give people living with hearing loss a solution that will help them hear even the finest details of sound more easily.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220816005068/en/
GN launches new technology platform to address the No.1 hearing aid challenge: hearing speech in noise (Photo: Business Wire)
Despite advances in hearing aid technology over the last 10 years, hearing speech in noisy environments is still a challenge for people with hearing loss. In fact, 80% of people who wear hearing aids describe hearing in noise as a key challenge.1 To address this, ReSound OMNIA has been engineered to sound natural while still delivering 150% improvement in speech understanding compared to current hearing aids.2,* In a clinical study, 20% of respondents had issues with the sound of their own voice when wearing hearing aids.3 ReSound OMNIA also addresses this challenge by enhancing the user’s perception of ‘own voice’, so it sounds natural which contributes to higher satisfaction, leading to improved retention of hearing aids.
For additional sound performance and comfort, ReSound introduces Check My Fit, a new, first-of-its-kind feature in the ReSound Smart3D App. It gives users guidance to wear their hearing aids correctly via a quick ear selfie. Wearing hearing aids incorrectly can result in up to 11dB of sound escaping the ear, reducing the ability to hear considerably.4 Check My Fit also works with other ReSound hearing aids to help people enjoy sound fully without unnecessary trips to the audiologist.
“At GN Hearing, we know that hearing in noise and hearing aid comfort are both critically important to hearing aid users”, says GN Hearing CEO, Gitte Aabo. “The new ReSound OMNIA hearing aids show what we can achieve when we put the needs of each individual user at the center of our design process. We address the difficult challenges such as speech understanding in noise so that they can enjoy every conversational nuance.”
Whether users choose to stream phone calls or music to their ears, they can connect naturally and hear it all with the highest quality through enhanced connectivity of ReSound OMNIA. Users can enjoy hands-free, crystal-clear phone calls at the touch of a button with iPhone and iPad**, and direct streaming from Android smartphones.
The new ReSound OMNIA hearing aids will be rolled out globally starting with the US and Canada on August 25, 2022, along with the equivalent Beltone Achieve line-up, in the popular Receiver-in-Ear (RIE) style. The ReSound OMNIA hearing aids are available in eight colors and in both rechargeable and non-rechargeable models. Also available from August 25, 2022, are GN Hearing’s recently launched Custom made by ReSound hearing aids in a Completely-in-Canal (CIC) style, to address more needs with a truly small fit, crafted for ease of use and all-day comfort.
GN will host a teleconference at 15:30 (3.30 pm) CEST, August 16, 2022. Please visit www.gn.com/investor to access the teleconference. Presentation material will be available on the website approximately one hour prior to the teleconference.
For more information, visit the ReSound website.
* The 150% increase represents a 4.36db increase compared to legacy ReSound hearing aids.
** ReSound OMNIA hands-free calls are compatible with iPhone 11 or later, iPad Pro 12.9-inch (5th generation), iPad Pro 11-inch (3rd generation), iPad Air (4th generation), and iPad mini (6th generation) or later, with software updates iOS 15.3 and iPadOS 15.3 or later.
1MarkeTrak 10, 2019
2 Jespersen et al (2022)
3 Bennett et al (2020)
4 Yang et al (2022)
– ENDS –
NOTES TO EDITORS
ReSound is a recognised pioneer and innovator in hearing aids, which continues to set new standards to make life sound better for more people. Part of the GN Group, ReSound has unique access to cutting-edge competences from the audio world which enriches its medical-grade solutions with a deep understanding of user-centric design and lifestyle needs. By placing people at the center of innovation, ReSound consistently introduces game-changing experiences such as direct audio streaming from iPhone to hearing aids and remote care from hearing professionals via the user’s smartphone app. ReSound is a committed and trusted partner to leading hearing care professionals in over 100 countries around the world helping people hear more, do more and be more than they ever thought possible.
About GN Group
GN Group facilitates communication between people through its intelligent hearing, audio, video, and gaming technology. Inspired by people and driven by our innovation leadership, we leverage technological synergies to deliver unique and increasingly individualized user experiences in our products and solutions.
150 years ago, GN was founded with a truly innovative and global mindset. Today, we honor that legacy with world-leading expertise in the human ear, audio, video and speech, wireless technologies, miniaturization, and collaborations with leading technology partners. GN's solutions are marketed by the brands ReSound, SteelSeries, Jabra, Beltone, Interton, BlueParrott, Danavox and FalCom in around 100 countries. Founded in 1869, the GN Group employs 7,000 people and is listed on Nasdaq Copenhagen (GN.CO).
© 2022 GN Hearing A/S. All rights reserved. ReSound is a trademark of GN Hearing A/S. Beltone is a trademark of GN Hearing Care Corporation. Apple, the Apple logo, iPhone, iPad, and iPod touch are trademarks of Apple Inc., registered in the U.S. and other countries. Android is a trademark of Google LLC.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
For further information, please contact:
Press and the media
Marie Schleimann Nordlund
Director of PR and Communication
Tel: +45 31 26 37 34
Steen Frentz Laursen
Vice President Corporate Communications
Tel: +45 45 75 07 21
Investors and analysts
Vice President, Investor Relations & Treasury
Tel: +45 45 75 03 33
Director, Investor Relations & Treasury
Tel: +45 45 75 92 57
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SoftServe Named as a Challenger in 2023 Gartner Magic Quadrant for Custom Software Development Services, Worldwide4.12.2023 18:31:00 CET | Press release
SoftServe, a premier IT consulting and digital services provider, today announced it has been named by Gartner® as a Challenger in the 2023 Magic Quadrant™ for Custom Software Development Services, Worldwide. SoftServe was recognized for its ability to execute and completeness of vision. “SoftServe is recognized throughout the market as a preferred partner for some of the world’s leading technology providers and enterprises,” said Alex Chubay, SoftServe’s CTO. “Our approach involves a holistic perspective encompassing business acumen, user experience, cloud and data engineering, along with cutting-edge technologies – such as Generative AI – that enable our clients to build award-winning digital products and transform their businesses.” Magic Quadrant reports are a culmination of rigorous, fact-based research in specific markets, providing a wide-angle view of the relative positions of the providers in markets where growth is high and provider differentiation is distinct. For more than
Limited Libations, Innovative Blending, Escapism Elixirs and More are Shaping the Way That Consumers Drink in 2024, Based on the Bacardi Cocktail Trends Report4.12.2023 16:40:00 CET | Press release
Bacardi Limited, the world’s largest privately held international spirits company, releases its fifth annual Bacardi Cocktail Trends Report, anticipating the key trends that will redefine cocktail culture and the spirits business in 2024. The report, created in collaboration with strategic foresight consultancy, The Future Laboratory (TFL), draws on insights from Bacardi-led and external research, interviews with bartenders and insights from The Future Laboratory to share the themes that are transforming flavor preferences, drink formats, and cocktail experiences in the coming year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231202332985/en/ Find out what's in store for 2024 with the Bacardi Cocktail Trends Report. (Graphic: Business Wire) “As 2024 arrives, people are looking to settle into the unsettled – welcoming tastes of optimism into our reality. In this landscape, people are reshaping cocktail culture, infusing it
Visa and Oxfam America to Explore Expanding Anticipatory Action Program to Bring Pre-Disaster Financial Support to the Philippines, Kenya, Colombia, and Puerto Rico4.12.2023 15:00:00 CET | Press release
During the 28th United Nations Climate Change Conference (COP28), Visa (NYSE: V), a global leader in digital payments, and Oxfam America, a part of the global Oxfam organization fighting inequality to end poverty and injustice, announced intent to collaborate to scale Oxfam’s Building Resilient, Adaptive and Disaster-Ready Communities (B-READY) project to deliver real-time streamlined money movement and relief payments to individuals and businesses in the Philippines, Kenya, Colombia, and Puerto Rico. B-READY unites parametric forecasting with community inputs to provide humanitarian assistance to individuals, communities, and businesses before a disaster strikes. Visa and Oxfam America intend to scale B-READY to create a mobile-based payment solution infrastructure to digitize humanitarian payments to help families, individuals, and small businesses protect themselves and their assets before a disaster. Combining data-driven insights from Visa with Oxfam’s record of disaster relief an
QPS Holdings, LLC Expands Operations in Springfield, Missouri4.12.2023 14:30:00 CET | Press release
QPS Holdings, LLC, a global contract research organization has expanded operations in Springfield, Missouri. The new facilities include a clinical (safety) laboratory, an updated self-contained pharmacy, and a new dedicated space to build and ship clinical trial kits. The 2,750-square-foot facility is fully operational as of the fall of 2023 and will give QPS significant flexibility in clinical research study operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231204471818/en/ QPS Missouri is a division of QPS Holdings, LLC, a global Contract Research Organization. QPS Missouri conducts Phase I-IV clinical trials in Springfield, Missouri, and has recently added a new safety laboratory, updated pharmacy, and clinical trial kit production facility. (Photo: Business Wire) The state-of-the art laboratory is equipped with the most up-to-date technologies for Chemistry, Urinalysis, Serology, Coagulation, and Hematology test
Merck Strengthens Oncology Portfolio Through Commercialization Agreement With Abbisko for Phase III Asset, Pimicotinib4.12.2023 14:00:00 CET | Press release
Merck, a leading science and technology company, today announced a license agreement with Abbisko Therapeutics Co. Ltd., Shanghai, China, for pimicotinib (ABSK021), which is currently being evaluated in a Phase III study for the treatment of tenosynovial giant cell tumor (TGCT). TGCT is a benign tumor of the joints that can cause swelling, pain, stiffness, and limited mobility of the affected joints. Treatment options for this disease, which can seriously affect patients’ quality of life, are very limited. The agreement grants Merck a license to commercialize pimicotinib in mainland China, Hong Kong, Macau and Taiwan, with an option for rest of world. “We have the opportunity through our partnership with Abbisko to deliver a first-in-class treatment for a critically underserved patient population in China and potentially beyond,” said Andrew Paterson, Chief Marketing Officer for the Healthcare business sector of Merck. “Pimicotinib provides an opportunity to address a significant unmet